Sign Up to like & get
recommendations!
2
Published in 2022 at "Vaccines"
DOI: 10.3390/vaccines10040615
Abstract: Mycobacterium tuberculosis infections remain a global health problem in immunosuppressed patients. The effectiveness of BCG (Bacillus Calmette–Guérin), an anti-tuberculosis vaccine, is unsatisfactory. Finding a new vaccine candidate is a priority. We compared numerous immune markers…
read more here.
Keywords:
mice;
control;
rbcg;
c3h mice ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Journal of immunology"
DOI: 10.4049/jimmunol.2200731
Abstract: COVID-19 has accounted for more than 6 million deaths worldwide. Bacillus Calmette-Guérin (BCG), the existing tuberculosis vaccine, is known to induce heterologous effects over other infections due to trained immunity and has been proposed to…
read more here.
Keywords:
calmette rin;
rchimera;
rbcg;
bacillus calmette ... See more keywords